/

Taiwanese Pharmaceuticals & Biotech Stocks

  • 7D-2.9%
  • 1Y9.3%
  • Avg. PE22.7x
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6547Medigen Vaccine BiologicsNT$275.005.8%154.6%NT$58.4bn/aP/S3798.8xn/an/a
4132Golden BiotechnologyNT$55.909.0%24.9%NT$7.4bn/aP/S79.1xn/an/a
6492Senhwa BiosciencesNT$196.001.3%69.7%NT$17.6bNT$167.00P/S27038.2xE144.2%n/a
6539DV BiomedNT$68.004.9%44.0%NT$4.0bn/aP/E13.5xn/a5.9%
6617Gongwin Biopharm HoldingsNT$201.500.5%122.9%NT$20.6bn/aP/S25272.8xn/an/a
4726Mycenax BiotechNT$42.101.3%11.2%NT$6.5bn/aP/E32.6xn/an/a
6575SyneuRx International (Taiwan)NT$45.901.2%8.6%NT$5.1bn/aP/B16.3xn/an/a
6610TWi BiotechnologyNT$17.655.4%-10.6%NT$1.2bn/aP/S955.6xn/an/a
4105TTY BiopharmNT$84.100.2%10.4%NT$20.9bNT$83.25P/E23.9xE19.2%4.8%
1762Chunghwa Chemical Synthesis & BiotechNT$65.300.9%5.8%NT$5.1bNT$91.00P/E8.4xE15.4%2.3%
6677Anxo PharmaceuticalNT$26.952.9%-23.5%NT$1.2bn/aP/E39.3xn/a0.9%
4191PharmadaxNT$38.301.2%0%NT$2.6bn/aP/S8.4xn/an/a
1701China Chemical & PharmaceuticalNT$24.200.4%-2.0%NT$7.2bn/aP/E12.5xn/a4.1%
6814Lukas BiomedicalNT$48.501.7%n/aNT$1.6bn/aP/S8.8xn/an/a
6817Winston Medical SupplyLtdNT$100.500.5%n/aNT$1.8bn/aP/E17.7xn/a3.0%
4172InnoPharmaxNT$15.000.3%-35.9%NT$1.3bn/aP/S8.4xn/an/a
6621UniPharmaNT$12.950.4%-8.8%NT$457.6mn/aP/S3.3xn/an/a
6661Welgene BiotechLtdNT$26.800%-12.4%NT$624.6mn/aP/E25.3xn/a4.1%
6461Intech BiopharmNT$19.950%-11.7%NT$2.0bn/aP/S87.1xn/an/a
4114Synmosa BiopharmaNT$25.150%11.6%NT$6.7bn/aP/E10.4xn/a1.2%
1795Lotus PharmaceuticalNT$85.300%0.2%NT$22.3bNT$115.80P/E15.4xE11.0%0.4%
3705YungShin Global HoldingNT$43.900%-9.3%NT$11.7bn/aP/E16.6xn/a4.6%
68083D Global BiotechNT$40.000%n/aNT$2.2bn/aP/S153.5xn/an/a
4160Genetics Generation AdvancementNT$24.500%-20.3%NT$594.1mn/aP/S1.3xn/a2.8%
Page 1 of 4